MCLEAN, Va., Aug. 20, 2010 (GLOBE NEWSWIRE) -- Exmovere Holdings, Inc (www.exmovere.com), a biomedical engineering company, today announced that Clinica of Virginia, LLC, its wholly owned subsidiary, which now provides local patients with affordable, quality medical services has signed contracts with major insurance providers, Medicare, and Medicaid. Further, electronic data interchanges (EDIs) are in place for most of the major insurance carriers. This will facilitate a cost-effective, secure and efficient transmittal of information which will greatly reduce expenses, improve accuracy, and reduce processing time. Medicaid and Medicare are currently in place with two major insurance carriers and others are expected to be online shortly. Furthermore, Clinica will soon accept HMO payments and hopes shortly to be accepting Medicare Part B. Along the lines of these advances, Clinica of Virginia LLC is in advanced talks with Tricare as well. Tricare is supplemental insurance and is offered by most military associations.
Establishing these important conduits to both government and private insurance companies is critical in Clinica 's strategy of providing affordable and quality healthcare solutions to its clients. In addition to these ongoing advances in establishing reimbursement and the advantages they will have for patients, this is a major validation of the company as a viable healthcare provider. Exmovere VP and COO Cheyenne Crow commented, "These incremental yet important steps are critical to establishing an easy, user friendly, and economical environment for our clients. After all, it is about the patients and making their lives a little easier which is what brought about the inception of Clinica in the first place. The broader a reimbursement net we can cast, the easier it will be for patients and the more operationally efficient it will be for Clinica."
Clinica of Virginia LLC, with its first internal medicine and geriatric care medical clinic at Mosby Tower in downtown Fairfax, Virginia, plans on not only offering quality affordable healthcare but also providing patients unique access to Exmovere's biosensor-based, remote patient monitoring and mobility products. Within 6 months, Clinica's staff will be able to observe patient emotional states in the waiting area and examination rooms, monitor patient vital signs remotely and integrate all of these data in patient electronic health records. Exmovere will also develop biofeedback products for exclusive use at Clinica locations, with an emphasis on treating stress, insomnia, incontinence and sexual disorders. Over time, Clinica will expand its footprint of such clinics and drive these data mining activities in order to show the relationship between human emotion and biological outcomes. The foundation of all these activities will be the continual expansion of reimbursement for not only the services offered at these clinics but also Exmovere's important product offerings. Data driven validation will show over time how important human emotional status is to human health and why its use should be supplemental to the five vital signs in diagnosis.
Patients interested in scheduling appointments at Clinica in Fairfax should call 571-432-0700.
The logo for Clinica of Virginia LLC can be found at: https://www.issuerdirect.com/corporate/mediaroom/69052
Exmovere Holdings, Inc. is focused on government and consumer applications for healthcare, mobility, and security and the practical applications of the study of human emotion. Clinica of Virginia LLC will be a major component of this ongoing effort as the company pushes forward its message that human emotion is a predictor of forward behavior patterns. Further inquiries into the company, its strategic vision for Clinica or any of its innovative products can be directed to the below.
The Exmovere Holdings, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7861
Certain of the above statements contained in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Actual results, events, and circumstances (including future performance, results, and trends) could differ materially from those set forth in such statements due to various factors, risks, and uncertainties, including, but not limited to, risks associated with the company's future growth and operating results, the uncertainty of market acceptance of the company's products, technological change, competitive factors, and general economic conditions. Except as otherwise required to be disclosed in periodic reports required to be filed by companies registered under the Exchange Act by rules of the Securities and Exchange Commission, the company has no duty and undertakes no obligation to update such statements.